Enovis (ENOV) EBT Margin Growth (1y) (2011 - 2026)
Analysis
Enovis (ENOV) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -719.00 |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 236.00 |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 295.00 |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 687.00 |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 88.00 |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 374.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -938.00 |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 343.00 |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 165.00 |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 583.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 583.00 |
| Apr 3, 2026 | 1,037.00 |
| Dec 31, 2025 | 3,160.00 |
| Oct 3, 2025 | -9,484.00 |
| Jul 4, 2025 | 66.00 |
| Apr 4, 2025 | 509.00 |
| Dec 31, 2024 | -12,178.00 |
| Sep 27, 2024 | -232.00 |
| Jun 28, 2024 | -70.00 |
| Mar 29, 2024 | -797.00 |
| Dec 31, 2023 | 230.00 |
| Sep 29, 2023 | 1,429.00 |
| Jun 30, 2023 | -3,398.00 |
| Mar 31, 2023 | 266.00 |
| Dec 31, 2022 | 554.00 |
| Sep 30, 2022 | -1,477.00 |
| Jul 1, 2022 | 4,236.00 |
| Apr 1, 2022 | -2,150.00 |
| Dec 31, 2021 | 1,126.00 |
| Oct 1, 2021 | -1,014.00 |